Sigilon Therapeutics (SGTX)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	20.91 mm	20.91 mm	20.91 mm	20.91 mm	20.91 mm	20.91 mm
Cash burn (monthly)	7.21 mm	1.25 mm	2.48 mm	2.57 mm	1.39 mm	2.73 mm
Cash used (since last report)	116.77 mm	20.24 mm	40.13 mm	41.61 mm	22.43 mm	44.21 mm
Cash remaining	-95.86 mm	666.15 k	-19.22 mm	-20.70 mm	-1.52 mm	-23.30 mm
Runway (months of cash)	-13.3	0.5	-7.8	-8.1	-1.1	-8.5

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q2 2023

SGTX institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	19	34	-44.1%
Opened positions	3	5	-40.0%
Closed positions	18	5	+260.0%
Increased positions	0	6	EXIT
Reduced positions	14	6	+133.3%

13F shares	Current	Prev Q	Change
Total value	27.03 bn	16.64 bn	+62.4%
Total shares	11.08 mm	29.07 mm	-61.9%
Total puts	14.00	700.00	-98.0%
Total calls	13.00 k	26.90 k	-51.7%
Total put/call ratio	0.0	0.0	-95.9%

Largest owners	Shares	Value	Change
Flagship Ventures Fund V	8.89 mm	$426.93 mm	0.0%
LLY Eli Lilly and	1.01 mm	$3.97 mm	-63.2%
Flagship Pioneering	797.72 k	$17.96 bn	-92.3%
Canada Pension Plan Investment Board	114.24 k	$2.57 bn	-92.3%
FMR	78.80 k	$1.77 bn	-92.5%
Harbourvest Partners	56.98 k	$1.28 bn	-92.3%
Yakira Capital Management	39.75 k	$894.68 mm	NEW
State Of Wisconsin Investment Board	39.20 k	$882.44 mm	-92.3%
Vanguard	23.14 k	$520.97 mm	-92.3%
CSS	13.29 k	$299.20 mm	NEW

Largest transactions	Shares	Bought/sold	Change
Flagship Pioneering	797.72 k	-9.57 mm	-92.3%
LLY Eli Lilly and	1.01 mm	-1.74 mm	-63.2%
Canada Pension Plan Investment Board	114.24 k	-1.37 mm	-92.3%
BLK BlackRock	253.00	-1.05 mm	-100.0%
FMR	78.80 k	-975.80 k	-92.5%
Cercano Management	0.00	-884.92 k	EXIT
Harbourvest Partners	56.98 k	-683.76 k	-92.3%
State Of Wisconsin Investment Board	39.20 k	-470.43 k	-92.3%
Vanguard	23.14 k	-277.77 k	-92.3%
MS Morgan Stanley	6.42 k	-240.41 k	-97.4%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

SGTX insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
11 Aug 23	Eli Lilly and	Common Stock	Buy	Acquire P	No	No	14.92	1,718,493	25.64 mm	100
11 Aug 23	Flagship Ventures Fund V General Partner	Common Stock		Dispose U	Yes	No	14.92	113,960	1.70 mm	0
11 Aug 23	Flagship Ventures Fund V General Partner	Common Stock		Dispose U	Yes	No	14.92	683,760	10.20 mm	0
11 Aug 23	Robert R Ruffolo	Stock Option Common Stock	Sale back to company	Dispose D	No	No	7.51	3,754	28.19 k	0
11 Aug 23	Robert R Ruffolo	Stock Option Common Stock	Sale back to company	Dispose D	No	No	4.9984	683	3.41 k	0
11 Aug 23	Robert R Ruffolo	Stock Option Common Stock	Sale back to company	Dispose D	No	No	6.6439	683	4.54 k	0
11 Aug 23	Kavita Patel	Stock Option Common Stock	Sale back to company	Dispose D	No	No	4.9984	683	3.41 k	0
11 Aug 23	Kavita Patel	Stock Option Common Stock	Sale back to company	Dispose D	No	No	6.6439	683	4.54 k	0
11 Aug 23	Philip Ashton-Rickardt	Stock Option Common Stock	Sale back to company	Dispose D	No	No	0.75	8,845	6.63 k	0

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.